EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour‐Derived Extracellular Vesicles

Agustin Enciso-Martinez iD, Caroline Løppke iD, Joyce J Koene iD, Jade Ebbelaar iD, Meike van der Geest, Mandy Los, Emma P E M Boerrigter, Robert Dagil, Tobias Gustavsson, Elena E Vidal-Calvo iD, Ton G van Leeuwen iD, Roman I Koning iD und 6 weitere

Journal of Extracellular Vesicles · 2025-06 · 14 (6)

DOI: 10.1002/jev2.70106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 17.06.2025. Verfasst von Agustin Enciso-Martinez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Oncode Institute, Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Extracellular Vesicles, Chondroitin Sulfates, Pancreatic Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumour‐derived extracellular vesicles (tdEVs) are widely studied for their contribution to tumour progression and metastasis. These studies are hampered by the lack of specific markers to identify the tdEVs. Here, we show that oncofoetal chondroitin sulphate, a malignancy‐associated glycosaminoglycan modification, is present on tdEVs and can be targeted by the malaria VAR2CSA protein or C9 antibody. Using a fluorescently labelled recombinant VAR2CSA protein, we identified EVs from cancer cells in vitro by super‐resolution fluorescence microscopy and flow cytometry, as well as in a proof‐of‐concept study using plasma samples from pancreatic adenocarcinoma patients. Thus, the binding of VAR2CSA offers a tool to identify tdEVs, and can be used to explore their function and biomarker potential in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesChondroitin SulfatesPancreatic NeoplasmsAdenocarcinomaHumansCell Line, TumorBiomarkers, TumorAntigens, Protozoan

Stichwörter der Autor:innen

VAR2CSAbiomarkercancerextracellular vesiclesliquid biopsypancreatic adenocarcinoma

Substanzen

Chondroitin SulfatesBiomarkers, TumorVAR2CSA protein, Plasmodium falciparumAntigens, Protozoan

Autor:innen und Institutionen

  • Oncode Institute, Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Amsterdam UMC, University of Amsterdam, Biomedical Engineering & Physics, Meibergdreef 9; Cancer Center Amsterdam, Imaging and Biomarkers, University of Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam UMC, Laboratory of Experimental Clinical Chemistry, Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, University of Amsterdam, Amsterdam, the Netherlands.
  • Centre for translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • VAR2 Pharmaceuticals ApS, Frederiksberg, Denmark.
  • Electron Microscopy Facility, Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.

ORCID-Profile: Agustin Enciso-Martinez, Caroline Løppke, Joyce J Koene, Jade Ebbelaar, Elena E Vidal-Calvo, Ton G van Leeuwen, Roman I Koning, Ali Salanti, Rienk Nieuwland, Mette Ø Agerbæk, Peter Ten Dijke

Förderung

  • KWF Kankerbestrijding
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • ZonMw
  • Innovationsfonden
  • NNF BRIDGE Translational Excellence Program
  • Leiden University Fund
  • Novo Nordisk Foundation
  • Novo Nordisk Fonden

Zitieren

APA

Enciso-Martinez, A., Løppke, C., Koene, J. J., Ebbelaar, J., van der Geest, M., Los, M., Boerrigter, E. P. E. M., Dagil, R., Gustavsson, T., Vidal-Calvo, E. E., van Leeuwen, T. G., Koning, R. I., van Es, N., Salanti, A., van der Pol, E., Nieuwland, R., Agerbæk, M. Ø., & Ten Dijke, P. (2025). Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour‐Derived Extracellular Vesicles. Journal of Extracellular Vesicles, 14(6). https://doi.org/10.1002/jev2.70106

Vancouver

Enciso-Martinez A, Løppke C, Koene JJ, Ebbelaar J, van der Geest M, Los M, et al. Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour‐Derived Extracellular Vesicles. Journal of Extracellular Vesicles. 2025;14(6). doi:10.1002/jev2.70106

BibTeX
@article{EncisoMartinez2025,
  author = {Enciso-Martinez, Agustin and Løppke, Caroline and Koene, Joyce J and Ebbelaar, Jade and van der Geest, Meike and Los, Mandy and Boerrigter, Emma P E M and Dagil, Robert and Gustavsson, Tobias and Vidal-Calvo, Elena E and van Leeuwen, Ton G and Koning, Roman I and van Es, Nick and Salanti, Ali and van der Pol, Edwin and Nieuwland, Rienk and Agerbæk, Mette Ø and Ten Dijke, Peter},
  title = {Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour‐Derived Extracellular Vesicles},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  volume = {14},
  number = {6},
  doi = {10.1002/jev2.70106}
}
Kostenlos starten →